|
WO2014190311A2
|
|
Defective mismatch repair and benefit from bevacizumab for colon cancer
|
|
US2013251710A1
|
|
Methods to Expand the Eligible Patient Population for HER2-Directed Targeted Therapies
|
|
US2011262434A1
|
|
Methods to Expand the Eligible Patient Population for HER2-Directed Targeted Therapies
|
|
EP2304053A1
|
|
Identification and use of prognostic and predictive markers in cancer treatment
|
|
US2007254305A1
|
|
Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
|
|
CA2591716A1
|
|
Identification and use of prognostic and predictive markers in cancer treatment
|
|
US7056674B2
|
|
Prediction of likelihood of cancer recurrence
|
